New Trial Grows Many Mini-Livers in Patients’ Bodies

Cell therapy company LyGenesis will begin human clinical trials on a treatment for end-stage liver disease.

Screen Shot 2022 09 03 At 8 57 24 Am

A recent NewAtlas article discussed a unique new clinical trial that involves growing a multitude of mini-livers inside the body. The experimental treatment is intended for end-stage liver disease patients. The liver is a fairly resilient organ with a strong regenerative capacity. It can self-repair after damage incurred from ridding the body of toxins, but an unhealthy lifestyle can lead to liver disease, and eventually require a liver transplant.

Fresh from the show floor: pharma packaging innovations for 2026
Serialization mandates. Containment demands. Sterile barrier requirements. Our editors found the pharma packaging innovations addressing your biggest challenges at PACK EXPO Las Vegas. Get your free curated report now.
GET YOUR COPY
Fresh from the show floor: pharma packaging innovations for 2026